Home / 2021 / January / 11

Daily Archives: January 11, 2021

Philips highlights central role of healthcare in the home at All-Digital CES 2021

January 11, 2021

  • Beyond COVID-19, Philips spotlights care outside of hospital settings in unique, interactive virtual experience
  • Philips executives Deeptha Khanna and Jeroen Tas talk digital health tech in virtual press conference during CES 2021 Media Day
  • Philips named CES 2021 Innovation Awards honoree for outstanding technology products across personal and professional health

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced its participation in the first-ever, all-digital CES 2021, beginning today and running through Jan. 14. Since the initial outbreak of COVID-19 a year ago, healthcare has experienced a rapid transformation and acceleration of digital health technologies. During CES 2021, Philips will highlight a unique hybrid view of advanced technology solutions fast-tracking healthcare, moving outside the four walls of the hospital and into the home.

Telehealth, including tele-dentistry, virtual care and remote monitoring have played significant roles during the pandemic and will continue to play central roles in health and well-being post COVID-19 and beyond. At this year’s CES 2021, Philips has created an interactive virtual healthy neighborhood that visitors can self-navigate. The immersive experience brings three core storylines to life, demonstrating how Philips digital health technology is supporting consumers and patients alike during COVID-19. From first-time expecting parents, to at-risk people living with chronic – and often related – conditions like cardiac disease, diabetes, or sleep apnea, to those who want to improve their oral health, Philips will spotlight end-to-end solutions to help safely evaluate and monitor people to better manage healthcare at home.

Philips CES 2021 virtual press conference
Philips executives Deeptha Khanna, Chief Business Leader of Personal Health, and Jeroen Tas, Chief Innovation & Strategy Officer, will participate in the Philips CES 2021 virtual press conference on Monday, January 11 at 10:00 a.m. EST to discuss their vision and experience in the consumer and professional health tech space.

“Since the onset of the pandemic, we have witnessed a dramatic shift to online, with the majority of our activities now centered in the home. We’re working, shopping, educating and connecting with our caregivers, all from the comfort of our homes. In fact, nearly half of our Personal Health sales are now made online,” said Deeptha Khanna, Chief Business Leader, Personal Health, Philips. “We have also witnessed the reinvention of our homes as a core element of the healthcare pathway, with telehealth, virtual and remote care technologies as the key drivers for change during COVID-19. And these changes are here to stay.”

Philips spotlights remote monitoring, virtual care and digital health solutions at CES 2021
Pregnant mothers are a vulnerable population and may have several concerns and anxieties about the impact of COVID-19 infection on pregnancy [1]. Philips COVID-19 Fetal and Maternal solution within the Avalon product family, including patch and digital twin of the fetal monitor, allows clinicians to monitor vital signs of both mom and baby from home or an isolation room to help reduce unnecessary physical interactions between clinicians and patients.

In the belief that parents should be able to make decisions based on the best possible evidence, Philips and GSK have teamed up to equip Philips’ Pregnancy+ and Baby+ apps with comprehensive and reliable information about vaccine preventable diseases and the vaccines that are available. The apps, reaching a combined total of nearly 2 million parents worldwide every day, provide articles and videos about the importance of vaccination, together with a vaccination hub to help parents access comprehensive and reliable information to support conversations with their healthcare professionals, such as which vaccines are relevant and when they need to be administered. Parents are also invited to participate in on-line research to help to better understand their views on different vaccinations.

For people living with health conditions like diabetes or cardiac disease, Philips will highlight its recently introduced biosensor-based solutions for remote monitoring of at-risk chronic disease patients as they transition from the hospital into the home. Philips will also spotlight  its end-to-end, clinically proven sleep solutions, designed to help address chronic sleep conditions like sleep apnea from discovery, to diagnosis, through treatment and adherence – even from the home. Being showcased for the first time at CES is the Philips Mask Selector, the first and only clinically validated, 3D facial scanning solution that helps providers fit 9 out of 10 patients with the right mask from the start [2]. The proprietary Mask Selector algorithm offers a novel solution in the shift toward digitization of health care, helping to improve business efficiencies by reducing costs associated with fitting time and mask waste.

Philips debuts new Philips Sonicare 9900 Prestige at CES
As dentist offices closed for a significant period of time during the height of the pandemic, routine face-to-face dental check-ups came to a standstill. Taking care of oral health at home became more important than ever before. Earlier today, Philips announced the commercial launch of its most recent addition to the Sonicare line of advanced oral care products with the introduction of the Sonicare 9900 Prestige. This latest power toothbrush with Philips SenseIQ technology and in-built artificial intelligence helps make daily brushing as effective as possible. The Sonicare 9900 Prestige is designed to sense, adapt and care for a personalized approach to oral care. It is intuitive, adjusting its settings to a consumer’s personal brushing behavior.  For instance, when applying too much pressure, it automatically adjusts the brushing intensity.

Philips addresses key areas of health tech focus in CES panel speaker sessions
During CES 2021, Pat Baird, Regulatory Standards Specialist and Global Head of Software Standards at Philips will address the trustworthiness of AI in healthcare through the lens of the end user including physicians, consumers, professional and family caregivers, public health leaders, medical societies, and regulators. Joining Philips in the discussion on Trust and the impact of AI on healthcare are Dr. Jesse Ehrenfeld, MD, American Medical Association, and Christina Silcox, PhD, Managing Associate at the Duke-Margolis Center for Health Policy at Duke University. CES attendees can join the panel session, Jan. 12 at 10:15 a.m. EST.

Building sustainability and battling climate change
Robert Metzke, Global Head of Sustainability for Philips will also speak at CES during an in-depth fireside chat titled “Building Sustainability and Battling Climate Change.” Robert will give his views on how business leaders are increasingly acknowledging how critical sustainability is to the future. This session will premiere on Jan. 13 at 11:30 a.m. EST. Both speaker sessions will be available on demand for 30 days to all registered CES attendees following the event.

Philips named CES 2021 Innovation Awards honoree
On Dec. 15, the Consumer Technology Association (CTA)® announced the CES® 2021 Innovation Awards honorees, including those products recognized as Best of Innovation. Honorees are recognized for outstanding products, upcoming trends and how companies are using technology to change lives for the better. Philips been named a CES® 2021 Innovation Awards honoree recognized for multiple technology solutions across personal and professional health including the Philips Patient Monitoring Kit; the Philips Wearable Biosensor; the Philips Mask Selector; the Philips Sonicare Prestige 9900; and Philips Teledentistry.

Visit the Philips exhibitor showcase at the all-digital CES 2021 to learn more and follow @PhilipsLiveFrom for live updates throughout the event. While the Philips virtual healthy neighborhood experience is built for CES, the platform will be live throughout the year to continue to demonstrate both Personal Health and Connected Care technology solutions supporting consumer health.

[1] Covid-19 related anxiety and concerns expressed by pregnant and post-partum women – a survey among obstetricians (nih.gov): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445074/.
[2] 2019 Philips sponsored patient preference trial (n=310). Patients scanned using Mask Selector (n=153) vs. traditional fitting methods (n=157).

For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978-221-8919
E-mail : kathy.oreilly@philips.com
Twitter: @kathyoreilly

Laura Seikritt
Philips Global Press Office
Tel: +31 6 20740318
E-mail: laura.seikritt@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

Sonic power meets intelligent care, with the new Philips Sonicare 9900 Prestige

January 11, 2021

  • Introducing Philips Sonicare’s most advanced electric toothbrush with SenseIQ technology, designed to sense, adapt and care for a personalized approach to oral health
  • The Philips Sonicare app is powered by AI and works in perfect harmony with the toothbrush for real-time guidance and personalized recommendations to improve brushing habits
  • Featuring a clinically proven premium all-in-one brush head, which removes up to 20x more plaque [1], providing up to 15x healthier gums [2] and up to 100% less stains in less than 2 days [3]

Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announces the launch of the new Philips Sonicare 9900 Prestige with SenseIQ technology. Philips’ most advanced electric toothbrush is designed around you, providing an optimum, personalized cleaning experience by sensing your brushing style and adapting as you brush. Featuring a premium all-in-one brush head, it delivers the complete package for plaque removal, stain removal and gum care, so you can clean without compromise every single day.

SenseIQ technology delivers a personalized clean
As you brush, SenseIQ technology senses, adapts and cares for your teeth and gums, offering a truly unique and personalized brushing experience. Philips Sonicare 9900 Prestige uses sensors to detect the pressure you apply, the cleaning motions you use and the coverage you achieve – up to 100 times per second. The sensors also monitor how long and how often you brush.

Most of us apply too much pressure while brushing, which is why the new Philips Sonicare 9900 Prestige automatically adjusts intensity when you push too hard. Its state-of-the-art technology is simple and effortless, delivering the ultimate clean every time.

Premium all-in-one brush head
The premium all-in-one brush head is designed to brush away plaque, remove stains and care for gums without the need to switch brush heads and do guesswork on the modes. The angled bristles help remove up to 20x more plaque [4], whilst providing flex to compensate for any excess pressure. Triangular tips can remove up to 100% more stains in less than two days [5] and the longer bristles provide a deep clean for gums that are up to 15x healthier [6]. This is Philips’ all-time best brush head, helping you to achieve cleaner, whiter teeth and healthier gums with ease.

Philips Sonicare app
The Philips Sonicare app is powered by artificial intelligence and works in perfect harmony with the Philips Sonicare 9900 Prestige. Used together, the app provides real-time guidance on pressure, motion, position, duration and frequency of brushing. Progress reports by day, week, month and year are all available at the tap of a button, offering personalized recommendations and actionable steps for better brushing. Most of us don’t bring the phone to the bathroom while brushing. This new product has auto-syncing that keeps brushing data up-to-date, even when you don’t brush with the app by your side, so you can monitor your brushing progress from anywhere.

Sleek design
A simple push of the integrated power control lets you start brushing in an instant. And with no visible gaps or seams between the button and handle, Sonicare Prestige can always stay clean.

The elegant and compact travel case is wrapped in soft-touch vegan leather, making it both durable and stylish and can be slipped into any bag for carefree convenience. For extra ease, the case includes an integrated USB-C port and a USB charging cable, so you can easily recharge the toothbrush without removing it from the case.

[1] Versus a manual toothbrush in a clinical study
[2] Versus a manual toothbrush in six weeks in a clinical study
[3] Versus a manual toothbrush in a lab test
[4] Versus a manual toothbrush in a clinical study
[5] Versus a manual toothbrush in a lab test
[6] Versus a manual toothbrush in six weeks in a clinical study

For further information, please contact
Laura Seikritt
Philips Global Press Office
Tel: +31 6 20740318
E-mail: Laura.Seikritt@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

Conagen Begins Scale Up of Natural Sustainable Musk Macrocyclic Lactone Fragrance Materials

Musk portfolio includes familiar and completely novel aromas to bring precious, warm, and comforting scents to fine and household fragrances, personal care and beauty products.

Bedford, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) — Conagen announced today its breakthrough development in the commercial production of natural and sustainable macrocyclic musk lactones from natural substrates using its proprietary technology, further expanding its already extensive gamma-lactone portfolio.

Musk fragrance compounds are typically used as base note ingredients in perfumes. The natural sources of these compounds are found in glandular secretions of animals, such as musk deer and some plants. In low concentrations, musks are expansive, velvety, sensual and sweet. However, the fragrance industry overall has moved away from animal sources, and plant sources are scarce.  Currently, chemically synthesized substitutes with similar scents are available for use.

Conagen successfully bridged its gamma-lactone production technology with its lipid platform to expand its lactone portfolio to natural musk scent macrocyclic lactones.

Built upon the diversity of structures among natural lipids, Conagen’s macrocyclic musk portfolio contains diverse compounds representing a range of familiar and novel aromas, many of which have never before been commercially available. This variety of characteristics creates a wider spectrum of fragrance application options for manufacturers that use musk macrocyclic lactones in their products.

“The expansion of Conagen’s lactone platform to macrocyclic lactones with musk fragrances adds to our momentum in meeting consumers’ demand for nature-based, clean ingredients,” said Dr. Casey Lippmeier, VP of innovation at Conagen.

“We have found new ways to make various classes of natural lactones.  I am excited by the new prospects our musk lactones bring as they have grown rapidly from a proof-of-concept technology to commercial production.  Expect many more innovative, natural lactones coming from our technology,” said Dr. Lippmeier.

For the last 10 years, Conagen has successfully developed one of the largest portfolios of ingredient products for its customers, including science-based Blue California ingredients.

“The technology breakthrough is impressive on its own, but equally so is the speed at which Conagen was able to take musk from idea to scaleup – five short months.  That’s the partner you want to have in these competitive markets,” said Kathy Oglesby, head of flavor and fragrance at Blue California.

About Conagen

Conagen is making the impossible possible. Our scientists and engineers use the latest synthetic biology tools to develop sustainable, nature-based molecules bio-manufactured into the highest quality products available. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. For more information, visit www.conagen.com

Attachments

Ana Arakelian
Conagen
+1.781.271.1588 and +1.781.353.9028
ana.arakelian@conagen.com

GAMCO International SICAV Announces the Launch of a new UCITS sub-fund: GAMCO Convertible Securities

RYE, N.Y., Jan. 11, 2021 (GLOBE NEWSWIRE) — GAMCO Investors, Inc. (NYSE:GBL) announced today that GAMCO International SICAV (Luxembourg), managed by Gabelli Funds, launched a new sub-fund, GAMCO Convertible Securities.

GAMCO Convertible Securities’ objective is to seek to provide current income as well as long term capital appreciation through a total return strategy by investing in a diversified portfolio of global convertible securities.

The Fund leverages the firm’s history of investing in dedicated convertible security portfolios since 1979. Multiple share classes will be available at launch and are tailored for Global institutional investors as well as select non-US retail investors. At the onset, the Fund will launch with an institutional founder’s class at a reduced fee.

Michael Gabelli, Managing Director and Director of Global Business Development for Gabelli noted, “The GAMCO Convertible Securities fund offers investors access to one of Gabelli’s core strategies within a UCITS compliant structure, providing daily liquidity via accumulating share classes and a distributing class. We are excited to bring an actively managed fund to the European and Global marketplace that will be dedicated to global convertible securities while factoring in ESG guidelines.”

Also commenting on the launch, Thomas Dinsmore, Co-Portfolio Manager said, “We are delighted to apply our combined 60+ years of convertible portfolio management experience to this new offering affording investors across the globe access to our active approach to converts. The convertible markets continue to provide a strong flow of new issuances as well as attractive investment opportunities.”

Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. The prospectus contains information about these and other matters and should be read carefully before investing. To obtain a prospectus, call +1-914-921-5135 or visit www.gabelli.com/sicav.

NO REGISTRATION STATEMENT HAS BEEN FILED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION (THE “SEC”) OR ANY STATE SECURITIES AUTHORITY WITH RESPECT TO THIS OFFERING. THE SHARES OF THE FUND HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1933 (THE “ACT”). THE SHARES MAY ONLY BE OFFERED AND SOLD IN OFFSHORE TRANSACTIONS (AS DEFINED IN REGULATION S UNDER THE ACT) TO NON – U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE ACT).

SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION

Our disclosure and analysis in this press release contain some forward-looking statements. Forward-looking statements give our current expectations or forecasts of future events. Such statements are subject to contingencies and uncertainties, some or all of which may be material. We direct your attention to the cautionary statements regarding forward-looking information set forth in documents on Gabelli’s website. We do not undertake to update publicly any forward-looking statements if we subsequently learn that we are unlikely to achieve our expectations or if we receive any additional information relating to the subject matters of our forward-looking statements.

Contact: Michael M. Gabelli
Managing Director
+1 (914) 921-5135
+44 (0)20 3206 2100
www.gabelli.com/sicav

MACC nabs four over issuing of certificates to contractors

Four people including an assistant director of a Federal agency were arrested here today by the Malaysian Anti-Corruption Commission (MACC) on suspicion of involvement with a syndicate issuing certificates to contractors without proper due diligence.

According to a source, the case involved issuing of certificates like for registration of contractors, vendors and service providers, Construction Industry Development Board certificates and those involving Bumiputera status in Sabah where bribery was involved.

The source said the syndicate was believed to have been operating for about a year whereby the applicant only needed to pay between RM500 and RM1500 to expedite issuing of such certificates without having to undergo the required process.

MACC Sabah director S. Karunanithy when contacted confirmed the arrests and said more people were expected to be hauled in.

However, he declined to divulge more details and advised any parties, specifically contractors who had information on corrupt activities to get such certification to come forward to assist investigations.

Source: BERNAMA News Agency

Student loses RM84,600 in digital currency scam

— A female student lost RM84,600 after being deceived by a digital currency investment scam advertised on Facebook.

Melaka Commercial Crime Investigation Department chief Supt E Sundra Rajan said in the incident on Jan 5, the 25-year-old victim was contacted by the suspect via WhatsApp and briefed about investing in Bitcoin.

He said the victim, who studies at a private higher learning institution, was promised a lucrative return within 72 hours, and was instructed to register on a website between Jan 5 and Jan 8.

“The victim made several payments to five different accounts in stages to buy bitcoin totaling RM84,600.

“The suspect continued to direct the victim to make payments until she ran out of money, which led the victim to inform her family members,” he said in a statement here today.

Sundra said the victim then lodged a police report on Jan 8 at the Tengkera Police Station and the case was being investigated under Section 420 of the Penal Code for fraud.

In the meantime, he advised the public not to be fooled by advertisements and offers to participate in investments that promise lucrative returns in a short time, as well as to obtain investment-related information through official sources such as Bank Negara Malaysia (BNM) and Securities Commission (SC).

Source: BERNAMA News Agency

Man slips on bridge, falls to his death

A man met his death after slipping and falling in the area of a collapsed bridge leading from Jalan Belimbing to Jalan Sri Makmur, Maran about 82 kilometres from here, after sending groceries to his friend last night.

Maran district police chief DSP Norzamri Abd Rahman said the victim, Ng Eng Fui, 47, was believed to have fallen around 10.30 pm while inspecting repair work by staff of the Public Works Department (JKR) at the bridge.

“Part of the bridge structure collapsed believed to be due to the strong current of the floods on Jan 3 and warning signs had been installed at the scene.

“The victim allegedly wanted to walk on the bridge at his own risk even though it was not allowed.

It is understood that he was approached the location of the repairs after delivering the goods,” Norzamri said when contacted, here, today.

Norzamri said the initial investigations found that the victim’s head had been hit by the iron or concrete from the bridge after it fell five metres and the victim was motionless when JKR workers tried to rescue him.

The victim’s body was taken to the Jengka hospital, Maran, and an autopsy done today confirmed that the cause of death was due to severe head injuries from the fall.

Source: BERNAMA News Agency